Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
4.160
+0.105 (2.59%)
At close: Jul 19, 2024, 4:30 PM
4.100
-0.060 (-1.44%)
Pre-market: Jul 22, 2024, 4:10 AM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $125.52 million as of July 22, 2024. Its market cap has increased by 66.92% in one year.
Market Cap
125.52M
Enterprise Value
41.91M
1-Year Change
66.92%
Ranking
Category
Stock Price
$4.16
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $125.52M, an increase of 121.78%. That is a compound annual growth rate of 9.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 125.50M | 0.72% |
Dec 29, 2023 | 124.60M | 18.67% |
Dec 30, 2022 | 105.00M | -73.42% |
Dec 31, 2021 | 395.00M | -24.17% |
Dec 31, 2020 | 520.90M | 30.00% |
Dec 31, 2019 | 400.70M | 1,125.38% |
Dec 31, 2018 | 32.70M | 247.87% |
Dec 29, 2017 | 9.40M | -28.24% |
Dec 30, 2016 | 13.10M | -54.67% |
Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Compass Therapeutics | 128.89M |
X4 Pharmaceuticals | 127.46M |
Immunic | 127.01M |
Annovis Bio | 126.57M |
Agenus | 125.79M |
Nuvectis Pharma | 123.35M |
Athira Pharma | 119.20M |
Werewolf Therapeutics | 118.20M |